Life Extension Magazine®

Thymosin alpha 1 as an adjuvant cancer therapy

Life Extension Advocated for Thymosin alpha 1 in 1981

In 1981 we published an article calling for approval of thymosin alpha 1 as an adjuvant cancer therapy and potentially, for reversing certain forms of immune senescence. We reprint this 1981 article to show how far behind Americans are in gaining access to medications used in other countries.

By Saul Kent.